Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
638
datasets available to search
ShareScore release 0.9.0
Dataset results
638 results for “erlotinib”
Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC
ClinicalTrials.gov study NCT00997334. IPD Sharing: NO. Countries: 1. Publications: 1.
MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT00769483. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00550836. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
ClinicalTrials.gov study NCT00970502. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT00353301. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II S
ClinicalTrials.gov study NCT01229150. IPD Sharing: NO. Countries: 1. Publications: 4.
Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer
ClinicalTrials.gov study NCT00585377. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01708954. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors
ClinicalTrials.gov study NCT01115803. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).
ClinicalTrials.gov study NCT00760929. IPD Sharing: YES. Countries: 11. Publications: 1.
A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations
ClinicalTrials.gov study NCT01609543. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
ClinicalTrials.gov study NCT00112736. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine
ClinicalTrials.gov study NCT00365144. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00287222. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00826449. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00855894. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations
ClinicalTrials.gov study NCT01342965. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas
ClinicalTrials.gov study NCT00532441. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib
ClinicalTrials.gov study NCT00570401. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
ClinicalTrials.gov study NCT00810719. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.